PDE3A Antibodies

Santa Cruz Biotechnology delivers a wide array of PDE3A monoclonal antibodies for research focused on understanding phosphodiesterase 3A in biological processes. PDE3A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphodiesterase 3A functions as a key enzyme that regulates intracellular levels of cyclic nucleotides, playing a vital role in numerous signaling pathways. Through the hydrolysis of cyclic AMP and cyclic GMP, phosphodiesterase 3A influences processes such as cell proliferation, differentiation, and apoptosis. The significance of phosphodiesterase 3A in cardiovascular health and its potential role in various diseases makes it an important target for therapeutic interventions. Ongoing research continues to uncover new functions and regulatory mechanisms of phosphodiesterase 3A in cellular processes. Understanding phosphodiesterase 3A's molecular interactions provides insights into disease development and potential treatment strategies. Research utilizing PDE3A monoclonal antibodies contributes to expanding knowledge in cell signaling pathways and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular and molecular processes.